Based on the data provided, the R&D budget for Health and Medical Sciences in the Netherlands is forecasted to remain stable at 0.19% of GDP from 2024 through 2028. Comparing this with the 2023 figure, which also stood at 0.19% of GDP, there are no expected year-on-year variations, indicating a static budget allocation over this period. Consequently, the Compound Annual Growth Rate (CAGR) over the last five years is 0%, reflecting no growth in the R&D budget for Health and Medical Sciences relative to GDP.
Future trends to watch for:
• Potential shifts in government policy or funding priorities that could increase or decrease the R&D budget.
• Changes in GDP that may affect the real-term value of the R&D budget.
• Emerging health and medical challenges that necessitate increased R&D investment.
• Developments in international collaboration or funding opportunities impacting national R&D investments.
